Comparison of Treatment Outcome After Collagenase and Needle Fasciotomy for Dupuytren Contracture: A Randomized, Single-Blinded, Clinical Trial With a 1-Year Follow-Up
- PMID: 27473921
- DOI: 10.1016/j.jhsa.2016.06.014
Comparison of Treatment Outcome After Collagenase and Needle Fasciotomy for Dupuytren Contracture: A Randomized, Single-Blinded, Clinical Trial With a 1-Year Follow-Up
Abstract
Purpose: This study compared the efficacy of collagenase treatment and needle fasciotomy for contracture of the metacarpophalangeal (MCP) joint in Dupuytren disease.
Methods: This is a prospective, single-blinded, randomized study with follow-up 1 week and 1 year after treatment. One hundred and forty patients with an MCP contracture of 20° or more in a single finger were enrolled, of whom 69 patients were randomized to collagenase treatment and 71 patients to needle fasciotomy. The patients were followed at 1 week and were examined by a physiotherapist after 1 year. Measurements of joint movement and grip strength were recorded as well as patient-perceived outcomes measured by the Unité Rhumatologique des Affections de la Main (URAM) questionnaire and a visual analog scale (VAS) for the estimation of procedural pain and subjective treatment efficacy.
Results: Eighty-eight percent of the patients in the collagenase group and 90% of the patients in the needle fasciotomy group had a reduction in their MCP contracture to less than 5° 1 week after treatment, and the median gains in passive MCP movement were 48° and 46°, respectively. The median VAS score for procedural pain was 4.9 of 10 in the collagenase group and 2.7 of 10 in the needle fasciotomy group. After 1 year, 90% of the patients in both groups had full extension of the treated MCP joint. One patient in each group had a recurrence of the contracture. The median improvement in URAM score was 8 units in both groups and the VAS estimation of treatment efficacy by the patients was 8.7 of 10 in both groups.
Conclusions: There was no significant difference between the treatment outcomes after collagenase and needle fasciotomy treatment after 1 year.
Type of study/level of evidence: Therapeutic I.
Keywords: Dupuytren; collagenase; needle aponeurotomy; needle fasciotomy; percutaneous needle fasciotomy.
Copyright © 2016 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture: A Randomized Controlled Trial with a Two-Year Follow-up.J Bone Joint Surg Am. 2018 Jul 5;100(13):1079-1086. doi: 10.2106/JBJS.17.01128. J Bone Joint Surg Am. 2018. PMID: 29975270 Free PMC article. Clinical Trial.
-
Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren's Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up.Plast Reconstr Surg. 2020 Jun;145(6):1464-1474. doi: 10.1097/PRS.0000000000006828. Plast Reconstr Surg. 2020. PMID: 32459776 Clinical Trial.
-
One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren's contracture: A two-centre prospective randomized clinical trial.J Hand Surg Eur Vol. 2016 Jul;41(6):577-82. doi: 10.1177/1753193415617385. Epub 2015 Dec 1. J Hand Surg Eur Vol. 2016. PMID: 26631343 Clinical Trial.
-
Collagenase Treatment Versus Needle Fasciotomy for Single-Digit Dupuytren Contractures: A Meta-Analysis of Randomized Controlled Trials.J Hand Surg Am. 2023 Dec;48(12):1200-1209. doi: 10.1016/j.jhsa.2023.08.008. Epub 2023 Sep 16. J Hand Surg Am. 2023. PMID: 37725027
-
Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.Bone Joint J. 2013 Aug;95-B(8):1094-100. doi: 10.1302/0301-620X.95B8.31822. Bone Joint J. 2013. PMID: 23908426 Review.
Cited by
-
Short-term efficacy and adverse effects of collagenase clostridium histolyticum injections, percutaneous needle fasciotomy and limited fasciectomy in the treatment of Dupuytren's contracture: a network meta-analysis of randomized controlled trials.BMC Musculoskelet Disord. 2022 Oct 28;23(1):939. doi: 10.1186/s12891-022-05894-6. BMC Musculoskelet Disord. 2022. PMID: 36307837 Free PMC article.
-
Bias in published randomized trials that compare collagenase injection with percutaneous needle fasciotomy in the treatment of Dupuytren disease: a systematic review.EFORT Open Rev. 2024 Jul 1;9(7):625-631. doi: 10.1530/EOR-23-0211. EFORT Open Rev. 2024. PMID: 38949161 Free PMC article.
-
Collagenase Clostridium histolyticum Versus Needle Fasciotomy for Primary Metacarpophalangeal Dupuytren Contracture: Five-Year Results from a Randomized Controlled Trial.JB JS Open Access. 2024 Nov 20;9(4):e24.00038. doi: 10.2106/JBJS.OA.24.00038. eCollection 2024 Oct-Dec. JB JS Open Access. 2024. PMID: 39569009 Free PMC article.
-
Collagenase Clostridium Histolyticum Versus Percutaneous Needle Fasciotomy for Dupuytren's Disease: A Systematic Review and Meta-Analysis.Life (Basel). 2025 Feb 8;15(2):259. doi: 10.3390/life15020259. Life (Basel). 2025. PMID: 40003669 Free PMC article. Review.
-
A randomised feasibility trial comparing needle fasciotomy with limited fasciectomy treatment for Dupuytren's contractures.Pilot Feasibility Stud. 2020 Jan 30;6:7. doi: 10.1186/s40814-019-0546-y. eCollection 2020. Pilot Feasibility Stud. 2020. PMID: 32021696 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous